Browse Title Index


 
Issue Title
 
Vol 24, No 6 (2017) The OncoSim model: development and use for better decision-making in Canadian cancer control Abstract   PDF   HTML
C.L. Gauvreau, N.R. Fitzgerald, S. Memon, W.M. Flanagan, C. Nadeau, K. Asakawa, R. Garner, A.B. Miller, W.K. Evans, C.M. Popadiuk, M. Wolfson, A.J. Coldman
 
Vol 15, No 1 (2008) The Ontario Cancer Research Ethics Board: A Central REB That Works Abstract   PDF
Maya Rani Chaddah
 
Vol 22, No 4 (2015) The optimal organization of gynecologic oncology services: a systematic review Abstract   PDF   HTML
M. Fung-Kee-Fung, E.B. Kennedy, J. Biagi, T. Colgan, D. D'Souza, L.M. Elit, A. Hunter, J. Irish, R. McLeod, B. Rosen
 
Vol 22, No 4 (2015) The organization of colposcopy services in Ontario: recommended framework Abstract   PDF   HTML
J. Murphy, N.P. Varela, L. Elit, A. Lytwyn, M. Yudin, M. Shier, V. Wu, S. El-Khatib
 
Vol 19, No 6 (2012) The pedicled myocutaneous flap as a choice reconstructive technique for immediate adjuvant brachytherapy in sarcoma treatment Abstract   PDF   HTML
S.C. Saba, A. Shaterian, C. Tokin, M.K. Dobke, A.M. Wallace
 
Vol 19, No 3 (2012) The Peter Brojde Lung Cancer Centre: a model of integrative practice Abstract   PDF   HTML
M. Grossman, J. Agulnik, G. Batist
 
Vol 23, No 3 (2016) The politicization of oncology drug funding reviews in Canada Abstract   PDF   HTML
C. Skedgel, T. Younis
 
Vol 20, No 3 (2013) The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study Abstract   PDF   HTML
G. Kasymjanova, M. Grossman, T. Tran, R.T. Jagoe, V. Cohen, C. Pepe, D. Small, J.S. Agulnik
 
Vol 24, No 6 (2017) The predictive effect of primary tumour location in the treatment of metastatic colorectal cancer: a Canadian consensus statement Abstract   PDF   HTML
A.B.K. Abrahao, S. Karim, B. Colwell, S. Berry, J. Biagi
 
Vol 17, No 4 (2010) The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer Abstract   PDF
G. Kasymjanova, N. MacDonald, J.S. Agulnik, V. Cohen, C. Pepe, H. Kreisman, R. Sharma, D. Small
 
Vol 23, No 4 (2016) The prevalence and nature of supportive care needs in lung cancer patients Abstract   PDF   HTML
M.E. Giuliani, R.A. Milne, M. Puts, L.R. Sampson, J.Y.Y. Kwan, L.W. Le, S.M.H. Alibhai, D. Howell, N. Abdelmutti, G. Liu, J. Papadakos, P. Catton, J. Jones
 
Vol 23, No 5 (2016) The prioritization preferences of pan-Canadian Oncology Drug Review members and the Canadian public: a stated-preferences comparison Abstract   PDF   HTML
C. Skedgel
 
Vol 23, No 6 (2016) The risk of colorectal cancer is not increased after a diagnosis of urothelial cancer: a population-based study Abstract   PDF   HTML
C.H. Harlos, H. Singh, Z. Nugent, A. Demers, S.M. Mahmud, P. M. Czaykowski
 
Vol 21, No 2 (2014) The road ahead for cervical cancer prevention and control Abstract   PDF   HTML
J.E. Tota, A.V. Ramana–Kumar, Z. El-Khatib, E.L. Franco
 
Vol 16, No 5 (2009) The road to cancer control goes through leukemia research Abstract   PDF
E.J. Freireich
 
Vol 15, No 2 (2008) The role of DNA hypermethylation and demethylation in cancer and cancer therapy Details   PDF
Moshe Szyf
 
Vol 24, No 2 (2017) The role of family physicians in cancer care: perspectives of primary and specialty care providers Abstract   PDF   HTML
J. Easley, B. Miedema, M.A. O'Brien, J. Carroll, D. Manca, F. Webster, E. Grunfeld, for the Canadian Team to Improve Community-Based Cancer Care Along the Continuum
 
Vol 16, No 4 (2009) The Role of HER2-targeted Therapies in Women with HER2-Overexpressing Metastatic Breast Cancer Abstract   PDF   Erratum
Susan Faye Dent, Shailendra Verma, Kathleen I Pritchard, Jean Latreille, Daniel Rayson, Mark Clemons, John R Mackey, Louise Provencher, Sunil Verma, Julie Lemieux, Stephen Chia, Bernice Wang
 
Vol 21, No 3 (2014) The role of interventional radiology in the management of hepatocellular carcinoma Abstract   PDF   HTML
N. Molla, N. Almenieir, E. Simoneau, M. Aljiffry, D. Valenti, P. Metrakos, L.M. Boucher, M. Hassanain
 
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective The role of molecular pathology in non-small-cell lung carcinoma— now and in the future Abstract   PDF   HTML
G.D.A. Brandao, E.F. Brega, A. Spatz
 
Vol 16, No 5 (2009) The Role of Neoadjuvant HER2-Targeted Therapies in HER2 Overexpressing Breast Cancers Abstract   PDF
J. Lemieux, M. Clemons, L. Provencher, S. Dent, J. Latreille, J. Mackey, K.I. Pritchard, D. Rayson, Sh. Verma, Su. Verma, B. Wang, S. Chia
 
Vol 13, No 5 (2006) The role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer: a systematic review and clinical practice guideline Details   PDF
Derek J Jonker, Robert Bryan Rumble, Jean Maroun
 
Vol 21, No 4 (2014) The role of palliative chemotherapy in hospitalized patients Abstract   PDF   HTML
P. Wheatley-Price, M. Ali, K. Balchin, J. Spencer, E. Fitzgibbon, C. Cripps
 
Vol 17, No 2 (2010) The role of photopheresis in the treatment of graftversus- host disease Abstract   PDF
J. Klassen
 
Vol 16, No 1 (2009) The role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic and Recurrent Non-Small Cell Lung Cancer: A Canadian National Consensus Statement Abstract   PDF
Peter Ellis, Wojciech Morzycki, Barbara Melosky, Charles Butts, Vera Hirsh, Flora Krasnoshtein, Nevin Murray, Frances A Shepherd, Denis Soulieres, Ming-Sound Tsao, Glenwood Goss
 
Vol 18, No 5 (2011) The role of transglutaminases in the pathophysiology of prostate cancer Abstract   PDF   HTML
R. J. Ablin, W. G. Jiang
 
Vol 14, No 6 (2007) The Role of Vaccine Therapy in Cancer: Biology and Practice Abstract   PDF
Jeffrey Schlom
 
Vol 23, No 1 (2016) The second Current Oncology Scholar’s Conference Abstract   PDF   HTML
Y. Cai
 
Vol 18 (2011): Progression-free Survival as an Endpoint in Antineoplastic Agents: A Canadian Perspective The significance of progression-free survival as an endpoint in evaluating the therapeutic value of antineoplastic agents Abstract   PDF   HTML
J.A. Maroun
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective The Soul’s Wisdom: Stories of Living and Dying Abstract   PDF
Mary L.S. Vachon
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference The Soul’s Wisdom: Stories of Living and Dying Abstract   PPT Presentation
Mary L.S. Vachon
 
Vol 25, No 3 (2018) The survivorship care plan: a valuable tool for primary care providers? Abstract   PDF   HTML
G. Chaput
 
Vol 17, No 5 (2010) The Terry Fox Research Institute’s Atlantic Dialogue on patient-centred care in a personalized treatment world Abstract   PDF
K. Curwin, M. Johnston, S. Sutcliffe
 
Vol 18, No 1 (2011) The Terry Fox Research Institute’s Ontario Dialogue: how will personalized medicine change health care? Abstract   PDF   HTML
K. Curwin, C.J. Paige, S. Sutcliffe
 
Vol 17, No 6 (2010) The Terry Fox Research Institute’s West Coast Dialogue: are we prepared for personalized medicine? Abstract   PDF
K. Curwin, C. Smith, S. Sutcliffe
 
Vol 21, No 5 (2014) The trastuzumab and vinorelbine combination: an alternative to taxane-based chemotherapy for early stage and locally advanced HER2+ breast cancer Abstract   PDF   HTML
K. Esfahani, C. Ferrario, P. Le, L. Panasci
 
Vol 24, No 2 (2017) The two solitudes of primary care and cancer specialist care: is there a bridge? Abstract   PDF   HTML
E. Grunfeld
 
Vol 23, No 1 (2016) The ultra-performance liquid chromatography tandem mass spectrometry method for detection and quantification of C4NP in rat plasma and its application to pharmacokinetic studies Abstract   PDF   HTML
J. You, L. Wang, F. Yang, J. Shang
 
Vol 18, No 1 (2011) The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian Paediatric Brain Tumour Consortium Abstract   PDF   HTML
U. Bartels, S. Baruchel, A.S. Carret, B. Crooks, J. Hukin, D. Johnston, M. Silva, D. Strother, B. Wilson, S. Zelcer, D. Eisenstat, L. Sung, E. Bouffet
 
Vol 21, No 2 (2014) The use of granulocyte colony– stimulating factors in a Canadian outpatient setting Abstract   PDF   HTML
S. Fine, M. Koo, T. Gill, M. Marin, M. Poulin-Costello, R. Baron, N. Mittmann
 
Vol 13, No 6 (2006) The use of prophylactic anticonvulsants in patients with brain tumours: A systematic review Details   PDF
Karen D Spithoff
 
Vol 22, No 2 (2015) The value-for-money of adjuvant aromatase inhibitors: time to put the debate to rest? Abstract   PDF   HTML
T. Younis, A. Groom
 
Vol 24, No 6 (2017) The views of patients with brain cancer about palliative care: a qualitative study Abstract   PDF   HTML
M. Vierhout, M. Daniels, P. Mazzotta, J. Vlahos, W.P. Mason, M. Bernstein
 
Vol 22, No 3 (2015) Third-party online surveys—science, selling, or sugging? Abstract   PDF   HTML
S. Mazzarello, M. Clemons, I.D. Graham, A.A. Joy, S. Smith, C. Jacobs
 
Vol 21, No 1 (2014) Thoracoscopic surgery for pulmonary oncocytoma, an uncommon neoplasm Abstract   PDF   HTML
B. Zhang, J. Jin, Z. Ye, H. Zheng
 
Vol 21, No 4 (2014) Thoughts on Jim Flaherty. When should physicians retire? Abstract   PDF   HTML
C. Jacobs, M. Clemons
 
Vol 22, No 3 (2015) Through a glass darkly: the mammography debate Abstract   PDF   HTML
C. Kaniklidis
 
Vol 23, No 3 (2016) Thyroid hormone autoantibodies: are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? Abstract   PDF   HTML
P. Mondello, M. Mian, V. Pitini, S. Cuzzocrea, A. Sindoni, M. Galletti, M. Mandolfino, D. Santoro, S. Mondello, C. Aloisi, G. Altavilla, S. Benvenga
 
Vol 19, No 5 (2012) Time to put an end to the “one size fits all” approach to bisphosphonate use in patients with metastatic breast cancer? Details   PDF   HTML
I. Kuchuk, M. Clemons, C. Addison
 
Vol 24, No 5 (2017) Timeliness of the oncology drug review process for public funding in Canada Abstract   PDF   HTML
T. Younis, C. Skedgel
 
Vol 22, No 5 (2015) To screen or not to screen for breast cancer? How do modelling studies answer the question? Abstract   PDF   HTML
R.G. Koleva-Kolarova, Z. Zhan, M. J.W. Greuter, T. L. Feenstra, G. H. De Bock
 
Vol 19, No 4 (2012) Tobacco and health: with or without pictures, nothing redeems smoking Abstract   PDF   HTML
Louis Z. G. Touyz
 
Vol 20, No 5 (2013) Tony Pawson Abstract   PDF   HTML
Friends at McGill University
 
Vol 19, No 3 (2012) Toward a portrait of Canadian cancer control Details   PDF   HTML
Heather Bryant
 
Vol 24, No 6 (2017) Toward improved goals-of-care documentation in advanced cancer: report on the development of a quality improvement initiative Abstract   PDF   HTML
I. Harle, S. Karim, W. Raskin, W.M. Hopman, C.M. Booth
 
Vol 21, No 2 (2014) Toward successful migration to computerized physician order entry for chemotherapy Abstract   PDF   HTML
J. Jeon, S. Taneva, V. Kukreti, P. Trbovich, A.C. Easty, P.G. Rossos, J.A. Cafazzo
 
Vol 25, No 1 (2018) Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA) Abstract   PDF   HTML
M. Uccello, M. Moschetta, G. Mak, T. Alam, C. Murias Henriquez, H.-T. Arkenau
 
Vol 24, No 5 (2017) Training oncoplastic breast surgeons: the Canadian fellowship experience Abstract   PDF   HTML
J. Maxwell, A. Aranaout, R. Hanrahan, M. Brackstone
 
Vol 23, No 2 (2016) Training the trainer: five practical considerations for your first five years in practice Abstract   PDF   HTML
C. Jacobs, A.A. Joy, M. Clemons, S. Mazzarello, M. Fralick
 
Vol 24, No 1 (2017) Trastuzumab in metastatic breast cancer after complete remission: an expensive commitment for an entire life? Abstract   PDF   HTML
D. Bernardi, M. Stefani, M. Boccalon, C. Raiti
 
Vol 15, No 1 (2008) Trastuzumab in the adjuvant setting: concurrent vs. sequential? It takes two to tango! Details   PDF
Sunil Verma
 
Vol 15, No 3 (2008) Trastuzumab: a cardiologist’s perspective Details   PDF
Marc André Côté
 
Vol 24, No 3 (2017) Trastuzumab-induced cardiotoxicity: testing a clinical risk score in a real-world cardio-oncology population Abstract   PDF   HTML
M. Rushton, C. Johnson, S. Dent
 
Vol 15, No 5 (2008) Treating Recurrent Cases of Squamous Cell Carcinoma with Radiotherapy Details   PDF
Jennifer Jing-Wen Wong, Dale Breen, Judith Balogh, Gregory J Czarnota, Juhu Kamra, Elizabeth Antonia Barnes
 
Vol 21, No 4 (2014) Treatment and follow-up strategies in desmoid tumours: a practice guideline Abstract   PDF   HTML
M. Ghert, X. Yao, T. Corbett, A.A. Gupta, R.A. Kandel, S. Verma, J. Werier
 
Vol 24, No 2 (2017) Treatment and outcomes for glioblastoma in elderly compared with non-elderly patients: a population-based study Abstract   PDF   HTML
E.R. Morgan, A. Norman, K. Laing, M.D. Seal
 
Vol 23, No 6 (2016) Treatment and outcomes for primary cutaneous extramedullary plasmacytoma: a case series Abstract   PDF   HTML
D.S. Tsang, L.W. Le, V. Kukreti, A. Sun
 
Vol 17, No 6 (2010) Treatment for glioblastoma multiforme: current guidelines and Canadian practice Abstract   PDF
A. Ghose, G. Lim, S. Husain
 
Vol 14, No 5 (2007) Treatment of Depression in Cancer Patients Details   PDF
Gary Rodin, Mark Katz, Nancy Lloyd, Esther Green, Rebecca K.S. Wong
 
Vol 19, No 6 (2012) Treatment of metastatic spinal cord compression: CEPO review and clinical recommendations Abstract   PDF   HTML
S. L'Esperance, F. Vincent, M. Gaudreault, J.A. Ouellet, M. Li, A. Tosikyan, S. Goulet, Comité de l'évolution des pratiques en oncologie
 
Vol 23, No 3 (2016) Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy—current perspectives Abstract   PDF   HTML
J. Spiliotis, E. Halkia, E. de Bree
 
Vol 21, No 3 (2014) Treatment outcomes for male breast cancer: a single-centre retrospective case–control study Abstract   PDF   HTML
M. Rushton, A. Kwong, H. Visram, N. Graham, W. Petrcich, S. Dent
 
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective Treatment paradigms for patients with metastatic non-small-cell lung cancer: first-, second-, and third-line Abstract   PDF   HTML
N.B. Leighl
 
Vol 22, No 6 (2015) Treatment patterns among Canadian men diagnosed with localized low-risk prostate cancer Abstract   PDF   HTML
C. Sandoval, K. Tran, R. Rahal, G. Porter, S. Fung, C. Louzado, J. Liu, H. Bryant
 
Vol 23, No 6 (2016) Treatment patterns and survival in patients with ALK-positive non-small-cell lung cancer: a Canadian retrospective study Abstract   PDF   HTML
S. Kayaniyil, M. Hurry, J. Wilson, P. Wheatley-Price, B. Melosky, J. Rothenstein, V. Cohen, C. Koch, J. Zhang, K. Osenenko, G. Liu
 
Vol 24, No 4 (2017) Treatment patterns and trends in patients dying of prostate cancer in Quebec: a population-based study Abstract   PDF   HTML
A. Dragomir, J. Rocha, M. Vanhuyse, F.L. Cury, W. Kassouf, J. Hu, A.G. Aprikian
 
Vol 19, No 5 (2012) Treatment recommendations for the use of bone-targeted agents in 2011— report from the 6th Annual Bone and the Oncologist New Updates meeting Abstract   PDF   HTML
I. Kuchuk, A. Paterson, E. Amir, M. Clemons, N. Bouganim
 
Vol 23, No 3 (2016) Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002–2009: a population-based cohort study Abstract   PDF   HTML
H.H. Thein, Y. Qiao, S.K. Young, W. Zarin, E.M. Yoshida, C. de Oliveira, C.C. Earle
 
Vol 18, No 4 (2011) Triple-negative and basal-like breast cancer: implications for oncologists Details   PDF   HTML
J. Lachapelle, W.D. Foulkes
 
Vol 18, No 4 (2011) Triple-negative breast cancers: an updated review on treatment options Abstract   PDF   HTML
K. B. Reddy
 
Vol 21, No 3 (2014) Truth be told— perspectives on openness Abstract   PDF   HTML
R.E. Hughes, J. Richards
 
Vol 22, No 1 (2015) Tumour inflammatory response: adding fuel to the fire? Abstract   PDF   HTML   Erratum
M. Valdes, M.R. Chasen
 
Vol 19, No 5 (2012) Tumour size predicts long-term survival among women with lymph node-positive breast cancer Abstract   PDF   HTML
S.A. Narod
 
Vol 15, No 5 (2008) Two Cases of Acrometastasis to the Hands and Review of the Literature Abstract   PDF
Candi J. Flynn, Cyril Danjoux, John Wong, Monique Christakis, Joel Rubenstein, Albert Yee, Darwin Yip, Edward Chow
 
Vol 21, No 6 (2014) Two cases of cutaneous drug eruption associated with temozolomide therapy for glioblastoma Abstract   PDF   HTML
E. Deluche, S. Leobon, F. Touraine, P. Clavère
 
Vol 21, No 3 (2014) Two indicators of hospital resource efficiency in cancer care Abstract   PDF   HTML
R. Rahal, J. Xu, S. Fung, H. Bryant
 
Vol 19, No 6 (2012) Ubiquitin pathway and ovarian cancer Abstract   PDF   HTML   CORRIGENDA
Z. Rao, Y. Ding
 
Vol 17, No 6 (2010) Umbilical metastasis: a case series of four Sister Joseph nodules from four different visceral malignancies Abstract   PDF
M. Palaniappan, W.M. Jose, A. Mehta, K. Kumar, K. Pavithran
 
Vol 21, No 5 (2014) Uncommon case of brain metastasis in a patient with a history of heavy smoking Abstract   PDF   HTML
M. Scharl, B. Bode, E. Rushing, A. Knuth, T. Rordorf
 
Vol 19, No 1 (2012) Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis Abstract   PDF   HTML
A. Bagnato, L. Rosanò
 
Vol 22, No 4 (2015) Unusual presentation of metastatic sebaceous carcinoma and its response to chemotherapy: is genotyping a right answer Abstract   PDF   HTML
V. Kumar, Y. Xu
 
Vol 21, No 5 (2014) Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer Abstract   PDF   HTML
M.A. Socinski
 
Vol 14, No 4 (2007) Updated recommendations from the Canadian National consensus meeting on HER2/neu testing in breast cancer Abstract   PDF
Wedad Hanna, Frances P O’Malley, P Barnes, R Berendt, L Gaboury, A Magliocco, N Pettigrew, S Robertson, S Sengupta, B Têtu, T Thomson
 
Vol 24, No 1 (2017) Updates from the 2016 American Society of Hematology annual meeting: practice-changing studies in untreated follicular lymphoma Abstract   PDF   HTML
C. Owen, D. MacDonald, A. Aw, A. Christofides
 
Vol 25, No 1 (2018) Updates from the 2017 American Society of Hematology annual meeting: practice-changing studies in relapsed and refractory mantle cell lymphoma Abstract   PDF   HTML
C. Owen, J. Kuruvilla, A. Christofides
 
Vol 25, No 1 (2018) Updates from the 2017 American Society of Hematology annual meeting: practice-changing studies in untreated chronic lymphocytic leukemia Abstract   PDF   HTML
C. Owen, C. Toze, A. Christofides
 
Vol 24, No 2 (2017) Uptake of a 21-gene expression assay in breast cancer practice: views of academic and community-based oncologists Abstract   PDF   HTML
M.A. O'Brien, S. Dhesy-Thind, C. Charles, M. Hammond Mobilio, N.B. Leighl, E. Grunfeld
 
Vol 18, No 3 (2011) Uptake of novel medical therapies in the general population Abstract   PDF   HTML
C. M. Booth, B. Rapoport
 
Vol 22, No 1 (2015) Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer Abstract   PDF   HTML
F. Santos, A. Dragomir, W. Kassouf, E. Franco, A. Aprikian
 
Vol 19, No 4 (2012) Use and delivery of granulocyte colony–stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy—single-centre experience Abstract   PDF   HTML
X. Zhu, N. Bouganim, L. Vandermeer, S. F. Dent, G. Dranitsaris, M. J. Clemons
 
1301 - 1400 of 1462 Items << < 9 10 11 12 13 14 15 > >>